ID

18512

Description

FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00086333

Lien

https://clinicaltrials.gov/show/NCT00086333

Mots-clés

Versions (1)
  1. 09/11/2016 09/11/2016 -
Téléchargé le

9 novembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Non-Small Cell Lung Carcinoma NCT00086333

Anglais

Eligibility Non-Small Cell Lung Carcinoma NCT00086333

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with pathologically confirmed stage iiib or iv nsclc with a minimum of 1 measurable baseline target lesion who have received no prior chemotherapy for metastatic disease and are not eligible for combined modality therapy with curative intent
Description

Non-Small Cell Lung Carcinoma | TNM clinical staging | Measurable Disease Quantity | Prior Chemotherapy Neoplasm Metastasis | Combined Modality Therapy Curative intent

Type de données

boolean

Alias
UMLS CUI [1]
C0007131
UMLS CUI [2]
C3258246
UMLS CUI [3,1]
C1513041
UMLS CUI [3,2]
C1265611
UMLS CUI [4,1]
C1514457
UMLS CUI [4,2]
C0027627
UMLS CUI [5,1]
C0009429
UMLS CUI [5,2]
C1276305
patients must have an ecog performance status of less than or equal to 2
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
-patients must have a tumor block available for documentation of ley antigen expression by immunohistochemistry
Description

Malignant Neoplasm Block Available | Lewis Y antigen Expression Documentation | Immunohistochemistry

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1533157
UMLS CUI [1,3]
C0470187
UMLS CUI [2,1]
C0298751
UMLS CUI [2,2]
C0017262
UMLS CUI [2,3]
C0920316
UMLS CUI [3]
C0021044
-fdg-pet imaging must be completed at a pet center approved by seattle genetics
Description

FDG-Positron Emission Tomography Completed

Type de données

boolean

Alias
UMLS CUI [1,1]
C3641247
UMLS CUI [1,2]
C0205197
patients must have adequate bone marrow and hepatic function
Description

Bone Marrow function | Liver function

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
-prior cytotoxic therapy for metastatic nsclc
Description

Cytotoxic therapy Non-small cell lung cancer metastatic

Type de données

boolean

Alias
UMLS CUI [1,1]
C0677881
UMLS CUI [1,2]
C0278987
-those with serious underlying non-malignant disease
Description

Disease Non-Malignant Serious

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C1518371
UMLS CUI [1,3]
C0205404
-patients with peripheral neuropathy > grade 2 are excluded from study
Description

Peripheral Neuropathy | CTCAE Grades

Type de données

boolean

Alias
UMLS CUI [1]
C0031117
UMLS CUI [2]
C1516728
-patients with iddm or niddm
Description

Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent

Type de données

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0011860
patients with known active viral, bacterial, or symptomatic fungal infection
Description

Virus Diseases | Bacterial Infections | Mycoses Symptomatic

Type de données

boolean

Alias
UMLS CUI [1]
C0042769
UMLS CUI [2]
C0004623
UMLS CUI [3,1]
C0026946
UMLS CUI [3,2]
C0231220
concomitant with other antineoplastic or experimental agents
Description

Antineoplastic Agents | Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C0003392
UMLS CUI [2]
C0013230
Retour au début de la page

Similar models

Eligibility Non-Small Cell Lung Carcinoma NCT00086333

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma | TNM clinical staging | Measurable Disease Quantity | Prior Chemotherapy Neoplasm Metastasis | Combined Modality Therapy Curative intent
Item
patients with pathologically confirmed stage iiib or iv nsclc with a minimum of 1 measurable baseline target lesion who have received no prior chemotherapy for metastatic disease and are not eligible for combined modality therapy with curative intent
boolean
C0007131 (UMLS CUI [1])
C3258246 (UMLS CUI [2])
C1513041 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C1514457 (UMLS CUI [4,1])
C0027627 (UMLS CUI [4,2])
C0009429 (UMLS CUI [5,1])
C1276305 (UMLS CUI [5,2])
ECOG performance status
Item
patients must have an ecog performance status of less than or equal to 2
boolean
C1520224 (UMLS CUI [1])
Malignant Neoplasm Block Available | Lewis Y antigen Expression Documentation | Immunohistochemistry
Item
-patients must have a tumor block available for documentation of ley antigen expression by immunohistochemistry
boolean
C0006826 (UMLS CUI [1,1])
C1533157 (UMLS CUI [1,2])
C0470187 (UMLS CUI [1,3])
C0298751 (UMLS CUI [2,1])
C0017262 (UMLS CUI [2,2])
C0920316 (UMLS CUI [2,3])
C0021044 (UMLS CUI [3])
FDG-Positron Emission Tomography Completed
Item
-fdg-pet imaging must be completed at a pet center approved by seattle genetics
boolean
C3641247 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
Bone Marrow function | Liver function
Item
patients must have adequate bone marrow and hepatic function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Cytotoxic therapy Non-small cell lung cancer metastatic
Item
-prior cytotoxic therapy for metastatic nsclc
boolean
C0677881 (UMLS CUI [1,1])
C0278987 (UMLS CUI [1,2])
Disease Non-Malignant Serious
Item
-those with serious underlying non-malignant disease
boolean
C0012634 (UMLS CUI [1,1])
C1518371 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
Peripheral Neuropathy | CTCAE Grades
Item
-patients with peripheral neuropathy > grade 2 are excluded from study
boolean
C0031117 (UMLS CUI [1])
C1516728 (UMLS CUI [2])
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent
Item
-patients with iddm or niddm
boolean
C0011854 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
Virus Diseases | Bacterial Infections | Mycoses Symptomatic
Item
patients with known active viral, bacterial, or symptomatic fungal infection
boolean
C0042769 (UMLS CUI [1])
C0004623 (UMLS CUI [2])
C0026946 (UMLS CUI [3,1])
C0231220 (UMLS CUI [3,2])
Antineoplastic Agents | Investigational New Drugs
Item
concomitant with other antineoplastic or experimental agents
boolean
C0003392 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial